Longjin Biotech (龙进生物) is a biopharmaceutical R&D firm focused on developing gene diagnostic reagents tied to tumor molecular targeted treatments. The company integrates production, research and development, and sales. Its main products include FISH probe reagents, PCR reagents, routine pathology reagents, automated staining instruments, and FISH imaging systems. The article reports a new financing in which 九强生物 intends to subscribe ¥32.0 million for a 25.21% equity stake. The piece does not provide operating metrics, round stage designation, or additional strategic details beyond the investment terms.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2024